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Open access under CC BThe peptide hormone ghrelin, which is the natural ligand of the membrane-bound growth hormone
secretagogue receptor (GHS-R), regulates overall body and cell growth, energy homeostasis, carbohy-
drate, protein and lipid metabolism and water electrolyte balance. It contains an O-acyl linked octanoyl
group on Ser3 and is the only peptide known to contain such a modiﬁcation. Using solution state NMR
spectroscopy and ultraﬁltration we found that human ghrelin binds to membrane-mimetic environments
via its octanoyl group as well as the aromatic moiety of Phe4. Relaxation enhancements in a paramag-
netic environment reveal that both the octanoyl group on Ser3 and the aromatic group on Phe4 are
inserted deep into the hydrophobic core of phosphocholine assemblies while the remaining peptide is
freely mobile in solution. In contrast, no binding was observed for des-octanoyl ghrelin. Thus, the octa-
noyl chain, together with the Phe4 aromatic group of ghrelin, functions as a membrane anchor. Our
results are in parallel with the previous ﬁnding that a bulky hydrophobic group on Ser3 and Phe4 of ghre-
lin are necessary for its function and thus indicate that membrane-binding is essential for ghrelin
function.
 2010 Elsevier Ltd.Open access under CC BY-NC-ND license.1. Introduction
The peptide hormone ghrelin, which was ﬁrst found in rat and
human stomachs, consists of 28 residues and contains an unusual
octanoyl modiﬁcation at Ser3.1–3 It was discovered using the or-
phan receptor strategy about 10 years ago as the natural ligand
for GHS-R (growth hormone secretagogue receptor), a G protein-
coupled receptor.1 Ghrelin stimulates the release of growth hor-
mone in the pituitary gland and the hypothalamus.1,4 The secreted
growth hormone regulates overall body and cell growth, energy
homeostasis, carbohydrate, protein and lipid metabolism, and
water electrolyte balance.1,5 Thus, ghrelin functions orexigenic
and increases food intake and body weight. This highly conserved
peptide hormone has been found in mammals but also in other
vertebrates, such as reptiles, amphibians, birds and ﬁsh.6 Molecular
features located in the N-terminal region, in particular residues
1–4 of the peptide, were found to be critical for its function.1 A
bulky hydrophobic group (e.g., an octanoyl or decanoyl fatty acid)
on the third amino acid has been shown to be required for maxi-
mum activity.1 A peptide corresponding to the ﬁrst four residues
of ghrelin (GSS(n-octanoyl)F) could activate the ghrelin receptor,
but not after removing also Phe4.7–9 In human cells, ghrelin isx: +43 316 380 9840.
ßauer), simonekosol@yahoo.
. Schrank), klaus.zangger@
Y-NC-ND license.synthesized as part of the 117 residue precursor protein preprogh-
relin, which is then transformed into ghrelin by posttranslational
modiﬁcations including proteolysis and acylation.1,2,10 The hydro-
xyl group of Ser3 is n-octanoylated which makes ghrelin the ﬁrst
known peptide or protein to be modiﬁed with octanoic acid.1,2,10
The acyl-modifying enzyme GOAT (ghrelin-O-acyltransferase),
which catalyzes the modiﬁcation of ghrelin has recently been iden-
tiﬁed.11,12 Acylation of peptides and proteins with long chain fatty
acids is known and studied for a long time.13–15 While the majority
of such modiﬁcations employ myristic- and palmitic acid, the acyl-
ation with the medium chain fatty acid octanoic acid was unknown
before the discovery of ghrelin. This hydrophobic moiety has been
proposed to act as an anchor at the human growth hormone secre-
tagogue receptor (hGHSR-1a).16,17 While myristoyl and palmitoyl
modiﬁcations on peptides have been frequently found to be in-
volved in peptide-membrane interactions, the involvement of
octanoyl chains in membrane or lipid binding has not been
reported so far. In fact, a molecular modeling study found an inter-
action of ghrelin with membranes near its C-terminus and pre-
dicted the octanoyl chain to point away from the membrane.18
Ghrelin has been shown to be unstructured in aqueous environ-
ment at low pH (1.0–3.0)10 as expected for a small linear peptide,
but shows some tendency for the formation of an a-helix as con-
ﬁrmed by CD spectroscopy.19 A molecular modeling study of ghre-
lin in the presence of a biological membrane predicted a loop
between residues Arg15 and Ser18 to bind to the membrane.18
The octanoyl group has been proposed to be necessary for binding
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recent NMR study measuring chemical shift perturbations of ghre-
lin in the presence of GHS-R1a in living cells found indications for
an interaction basically along the whole peptide chain.17 Interest-
ingly, these shift perturbations were not found when des-ghrelin,
a peptide identical to ghrelin but lacking the acylation of Ser3,
was used in the same study. The presence of an a-helix between
residues Gly8 and Lys20 in the bound state was postulated based
on the chemical shift index (CSI).17 Considering the role of peptide
attached myristoyl and palmitoyl chains as membrane-anchors
and the membrane localization of the GHS-R receptor, we carried
out an investigation of ghrelin and des-n-octanoyl-ghrelin (called
des-ghrelin further on) in the presence of membrane-mimetics
by NMR and ultraﬁltration experiments.
Generally, structural studies of small membrane-bound poly-
peptides are not possible by X-ray crystallography due to their
inherent ﬂexibility, but can be carried out by liquid NMR spectros-
copy, provided that the system under study is below the NMR size
limit to avoid excessive signal broadening. Thus, small membrane-
mimetic systems (typically micelles) have to be used.20–22 For the
present study we used dodecyl-phosphocholine micelles, which
are frequently used as a membrane-mimetic for NMR investiga-
tions. The zwitterionic DPC structurally resembles the structural
organization of biological membranes.21,22 It can well preserve
the 3D structure of bound peptides21,23,24 and proteins25 as well
as the catalytic activity of membrane-bound enzymes,26,27 and it
is commercially available in perdeuterated form. The binding of
peptides to micelles can be monitored by relaxation enhancements
in a paramagnetic environment.28–31 This approach yields the ori-
entation and immersion depth without chemical modiﬁcation of
the system under investigation. Here, we show that ghrelin binds
to membrane-mimetic systems (micelles and small unilamellar
vesicles) via insertion of its octanoyl chain and also the aromatic
moiety of Phe4 into the hydrophobic environment. Most of the
peptide, including the C-terminal region, is basically unaffected
by the membrane environment and stays unstructured in solution.
No indication of an interaction of des-ghrelin with membranes was
found.2. Material and methods
2.1. Materials
Human ghrelin [GSS(n-octanoyl)FLSPEHQRVQQRKESKKPPAKL
QPR] and human des-ghrelin were purchased from EZBiolab Inc.
(Carmel, IN, USA) with an approved purity (HPLC) of 98.60% and
97.62%, respectively. Perdeuterated dodecylphosphocholine (DPC-
d38, also known as FOS-CHOLINE-12-d38 ANAGRADE) was ob-
tained from Anatrace (Maumee, Ohio, USA). Gd(DTPA-BMA) was
puriﬁed from the MRI contrast agent Omniscan™ (Nycomed) as
previously described.30 All other chemicals were purchased from
Sigma-Aldrich (St. Louis, USA) in the highest purity available.
2.2. NMR spectroscopy
For the NMR spectra 2.31 mg of ghrelin (MW 3370.9 g/mol) or
2.50 mg des-ghrelin (MW 3244.7 g/mol) were dissolved in 50 mM
potassium phosphate buffer (pH 5.0), 100 mM DPC-d38 and D2O
were added to yield a H2O/D2O-ratio of 90/10. TOCSY and NOESY
spectra were acquired at 298 K on a Varian Unity INOVA 600 MHz
NMR spectrometer, equipped with a 5 mm HCN triple-resonance
probe and z-axis gradients. All other NMR experimentswere carried
out on aBrukerAvanceDRX500 MHzNMRspectrometerwith z-axis
gradients using a 5 mm TXI probe. To obtain paramagnetic relaxa-
tion enhancements, the samples were titrated with Gd(DTPA-BMA) (stock solution of 30 mM) to ﬁnal concentrations of 0.5, 1.0,
1.5 and 2.5 mM. The proton T1 relaxation times were obtained from
a series of eight 2D TOCSY spectra with a saturation recovery se-
quence at the beginning and recovery delays of 100, 300, 500, 700,
1000, 1500, 2000 and 3000 ms between saturation and start of the
TOCSY sequence. PREs were extracted from the slope of a straight
line obtained by plotting the relaxation rate against the concentra-
tion of the paramagnetic agent Gd(DTPA-BMA). Spectra were pro-
cessed using nmrPipe32 and analyzed by NMRView.33 Dissociation
constants of ghrelin and octanoic acid bound to DPC micelles were
determined bymonitoring chemical shift changes of ghrelin or octa-
noic acid upon the stepwise addition of a 600 mM stock solution of
DPC-d38. The DPC concentration was increased from 0 to 150 mM in
stepsof roughly10 mM.Fromtheobservedmeanchemical shifts the
dissociation constants were calculated by least square ﬁtting as de-
scribed previously.34 Using the chemical shift titration data, the
mole fraction partition coefﬁcient
Kp ¼ XAYA ð1Þ
can be obtained. In this equation XA is the mole fraction of the pep-
tide in the lipid phase and YA is the mole fraction of the peptide in
the aqueous phase35:
XA ¼
gpL
gL þ gpL
;
YA ¼
gpW
gW þ gpW
;
ð2Þ
where gL and gW are the moles of lipid and water and gpL and gpW
are the moles of the peptide in the lipid and aqueous phase, respec-
tively. Replacing gpW by gp  gpL, with gp being the total peptide
concentration, and solving Eq. (1) for gpL, we obtain:
gpL¼
KpgLgpþKpgpgWþ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
4ð1þKpÞKpgLgpþðKpgLþgpKpgpþgWÞ2
q
2ð1þKpÞ :
ð3Þ
The observed chemical shift of a peptide signal robs as a function of
gpL is given by
robs ¼ rpL
gpL
gp
þ rpW
gp  gpL
gp
; ð4Þ
where rpL and rpW are the chemical shifts of a peptide signal in the
lipid and water phase, respectively. The mole fraction partition
coefﬁcient Kp can be obtained by non-linear least square ﬁtting of
Eq. (4) after replacing gpL by Eq. (3).
2.3. Ultraﬁltration
Centrifugal ﬁlter devices with a 10 kDa cut-off (Millipore, Bille-
rica, USA) were loaded with ghrelin or des-acyl-ghrelin dissolved
in buffer (50 mM potassium phosphate, 0.02% NaN3, pH 5.0). To
investigate the binding of the peptides to lipid membranes, small
unilamellar vesicles (SUVs) were added to the samples to a ﬁnal
concentration of 2 mM. The vesicles consisted of TCDA (10,12-tri-
cosadiynoic acid, Sigma-Aldrich) and DMPC (Dimyristoylphosp-
hatidylcholine, Avanti Lipids) in a molar ratio of 6.5:17.36 The lipids
weredissolved andmixed in chloroform.After the solventwas evap-
orated, deionizedwater was added to the driedmixture until a total
lipid concentration of 2.4 mM was reached. The solution was
incubated at 80 C for 10 min, and sonicated for another 10 min.
Subsequently, the samplewas ﬁltered through a 0.45 lmpolyether-
sulfone-membrane ﬁlter (Puradisc Syringe Filter, Whatman) and
then irradiated with a UV lamp (245 nm) for 2 min as described
by Charych et al.37 Ghrelin and des-acyl-ghrelin in the absence and
presence of these SUVs were centrifuged in the ﬁlter devices at
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was used as a positive control.38 Analysis of the ﬁltrate and the
supernatant was carried out with ninhydrin staining of samples
loaded on TLC plates. Of each sample 2 ll were loaded on the plate
which was sprayed with 0.2% ninhydrin in ethanol to detect amino
acids.
3. Results
3.1. NMR spectroscopy
The one-dimensional 1H and two-dimensional TOCSY spectra of
ghrelin in aqueous solution at pH 5.0 were quite similar to the
NMR data previously reported at pH 1.010 and could therefore be
assigned by comparison with these spectra. All signals were found
in typical random coil regions (amide protons between 8.0 and
8.5 ppm and no methyl signals below 0.9 ppm). Des-ghrelin
showed very similar resonance frequency distributions with a poor
dispersion indicative of an intrinsically disordered conformation.
Upon the addition of DPC-d38 several signals of ghrelin shifted sig-
niﬁcantly (see Fig. 1a and b). The largest shift was found for the
amide proton of Ser3, which was shifted downﬁeld to 8.9 ppm.
Downﬁeld shifts (to higher frequencies) were also found for
Ser2-NH and Leu5-NH, while a series of shifts was recorded in
the region containing the side chain aromatic signals of Phe4 (be-
tween 7.0 and 7.2 ppm). In the aliphatic region a chemical shift
change was observed for the signal of the octanoyl alkyl chain
(Fig. 1b), indicating direct interactions with the forming micelles.
Aside from these signals most peaks of ghrelin retained their fre-
quencies in the presence of the membrane-mimetic, implying that
most residues of ghrelin remain in the aqueous phase. In contrast
to that, the spectrum of des-ghrelin was virtually unaffected uponFigure 1. One-dimensional 1H NMR spectra of ghrelin (a and b) and des-ghrelin (c and d)
and d) at 0 (red), 10 (green) and 20 mM (blue) DPC. Signals of ghrelin that shifted uponthe addition of DPC (Fig. 1c and d). The appearing signals in the ali-
phatic region (Fig. 1d) were attributed to residual protonated DPC
nuclei.
We examined the detailed mode of interaction with the mi-
celles by determining relaxation enhancements in a paramagnetic
environment. For this purpose the water soluble, inert paramag-
netic agent Gd(DTPA-BMA)39 was added to the samples, resulting
in an environment comparable to a paramagnetic solvent.30,39,40
Solvent exposed residues will therefore show high PRE values,
while the combined PRE, integrated over the whole paramagnetic
environment, decreases with 1/r3 (r being the distance to the clos-
est paramagnetic center) for nuclei further inside the micelle.30,31
To extract PREs we used series of 2D saturation recovery TOCSY
spectra obtained at different Gd(DTPA-BMA) concentrations to
determine enhancements of T1 times. Only well-resolved, clearly
assigned signals in the two-dimensional spectra of ghrelin and
des-ghrelin were used to extract PREs (see Fig. 2). The PREs corre-
spond to the slopes of lines obtained by least square ﬁtting of lon-
gitudinal relaxation rates R1 as a function of the Gd(DTPA-BMA)
concentration (Fig. 3). In ghrelin high PREs (>1.0) were found for
signals belonging to residues Gly6, His9, Val12 and Ala23. Much
lower values were recorded for Phe4 and in particular for the octa-
noyl side chain. The protons on C3 and C2 of the octanoyl chain had
the lowest PREs. Other protons of the octanoyl chain could not be
analyzed due to overlap with residual signals of DPC. Ser3 and
Phe4 showed rather low PREs for the protons 3Ha, 4Ha and espe-
cially 4.Hd, a proton located in the aromatic ring. The low values
observed for the alkyl chain and the aromatic moiety can only be
explained by their positioning deep inside the micelle. In contrast,
all experimental PREs of des-ghrelin were very high, indicating free
accessibility of the protons to the solvent. The PRE of 4Ha is rela-
tively low for ghrelin, but much higher for des-ghrelin. In order to, showing overlays of the aromatic and NH regions (a and c) and alkyl chain region (b
the addition of DPC are annotated.
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Figure 2. Fingerprint region of a two-dimensional TOCSY spectrum of ghrelin at
600 MHz. The most signiﬁcant downﬁeld shift is seen for Ser3. Signals which could
be used for PRE determinations, because they are not overlapped and gave a
correlation coefﬁcient close to 1 in the least square ﬁtting, are underlined.
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brane-binding, we determined the dissociation constants Kd, mole
fraction partition coefﬁcients Kp and unitary Gibbs free energies
DG0u of ghrelin and also of free octanoic acid bound to DPC micelles
by NMR titration experiments. Differences in chemical shifts could
be observed upon the addition of DPC to solutions of 1.0 mM octa-
noic acid or 1.14 mM ghrelin. The dissociation constants were ob-
tained by least square ﬁtting of observed chemical shifts as a
function of DPC concentration as previously described.34 Assuming
an aggregation number of 54 for DPC micelles20 and a 1:1 (ligand/
micelle) complex of ghrelin and octanoic acid bound to DPC mi-
celles, dissociation constants of 6 lM and <0.1 lM, were obtained
for octanoic acid and ghrelin, respectively. Due to the inaccuracy of
NMR-derived dissociation constants in case of relatively tight bind-
ing only an upper limit can be derived for ghrelin. The mole frac-Figure 3. Transverse relaxation rates plotted as a function of Gd(DTPA-BMA) concentrati
the octanoyl chain of ghrelin is depicted by a dash-dotted line. The steeper the line thetion partition coefﬁcients are 8.1  106 and 1.7  106 and DG0u is
9.5 kcal/mol and 8.6 kcal/mol for ghrelin and octanoic acid,
respectively.
3.2. Ultraﬁltration
Acylated ghrelin with a molecular weight of 3371 Da can easily
pass a 10 kDa cutoff ultraﬁltration membrane. After adding 2 mM
TCDA-DMPC vesicles no peptide was found in the ﬂow through
solution, but only in the retentate as detected by staining with nin-
hydrin. With a size of 100–200 nm, these vesicles could not pass
the ﬁlter membrane with pore sizes of approximately 5 nm. The
des-acyl form of ghrelin on the other hand was able to pass the ﬁl-
ter in the presence and absence of liposomes in the buffer.4. Discussion
4.1. NMR spectroscopy
As previously reported, ghrelin has no well deﬁned secondary
structure in aqueous solution at low pH,10 which is quite typical
for small linear peptides. NMR spectra of ghrelin at pH 5.0 are quite
similar to the reported acidic data and thus indicated that even at
moderate pH ghrelin is intrinsically disordered, at least on the
NMR time scale. However, short-lived structured conformers as
found by molecular modeling and CD spectroscopy18,19 cannot be
excluded. The resonance frequencies of ghrelin, which are close
to random coil values, were partially becoming better dispersed
upon the addition of DPC, indicating interaction with this mi-
celle-forming zwitterionic detergent. Larger shifts were found for
Ser2-NH, Ser3-NH, octanoyl-aliphatics, Phe4-aromatics and Leu5-
NH while most other signals were virtually unaffected by the addi-
tion of DPC. These chemical shift differences are a strong indication
of binding to the micelles via the hydrophobic part of ghrelin,
encompassing the octanoyl side-chain on Ser3 and the following
Phe4. Due to the continuous shifting of NMR signals of ghrelin
upon the addition of DPC there must be exchange between free
and micelle-bound peptide. Therefore, binding cannot be consid-
ered a static process of ghrelin being attached to the micelleson for several signals of ghrelin (full line) and des-ghrelin (dashed line). The signal of
higher the PRE and thus the closer to the solvent the proton is located.
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ative amounts of free and bound peptide being determined by the
binding strength. Since the NMR signals of free and bound peptide
are averaged the residence time in each of these states has to be
short on the NMR time scale, that is, <10 ms.
Posttranslationally introduced myristoyl and palmitoyl groups
on peptides have been known to mediate peptide-membrane
interactions.13 However, ghrelin is the only known peptide with
an octanoyl chain and the potential role of this comparably short
alkyl chain as a membrane anchor has not been shown previously.
In fact, a theoretical study found that the octanoyl group does not
interact with membranes, but instead points into the aqueous
phase.18 However, the importance of this chain in attaching ghrelin
to the micelle is seen by the absence of chemical shift changes in
des-ghrelin upon the addition of DPC. Apparently, removing the
octanoyl chain also abolishes micelle interactions. The nearby
hydrophobic phenylalanine is not sufﬁcient for membrane attach-
ment although it likely strengthens the binding of ghrelin to mem-
branes via additional hydrophobic interactions. More quantitative
information about the interaction with DPC micelles was obtained
through relaxation enhancements in a paramagnetic environment.
Most residues of ghrelin for which unambiguous PREs could be ob-
tained showed very high PREs indicative of their location outside
the micelle, in the aqueous phase. The lowest PREs were found
for the protons on C3 and C2 of the octanoyl chain which implies
that they are furthest away from the paramagnetic solvent and
thus most deeply buried inside the micelle. In addition, the side
chain aromatic Hd signal of Phe4 also showed a rather low PRE,
which can only be explained by its insertion into the micelle. A
schematic depiction of ghrelin and des-ghrelin with the experi-
mental PREs, indicating the positioning of ghrelin relative to the
micelle is shown in Figure 4. An exact positioning of the immersed
nuclei within the micelle is prevented by the irregular shape of the
DPC micelles with most of ghrelin outside. The undeﬁned surfaceFigure 4. Schematic diagrams of ghrelin and des-ghrelin indicating their location relativ
[s1 mM1].prevents the direct translation of PREs to immersion
depths.28,30,31,40 On the other hand the much higher PREs found
for des-ghrelin are in accordance with the absence of chemical
shift differences and thus clearly corroborate that des-ghrelin does
not interact with DPC micelles. The ghrelin receptor is homologous
to the motilin receptor and a homology has also been found be-
tween ghrelin and motilin by amino acid sequence alignment.
Therefore, ghrelin and motilin have been described as being struc-
turally and functionally related.2,41 However, motilin forms a well-
structured a-helix in membrane-mimetics,42 and thus a similarity
is not seen beyond the sequence. To conﬁrm the importance of the
octanoyl chain for membrane-binding, we employed another
technique as well as another membrane-mimetic. We used ultraﬁl-
tration with 10 kDa molecular weight cutoff membranes and
TCDA-DMPC vesicles. Although SUVs have intrinsically a high
number of defect states and therefore a different partitioning
behavior compared to micelles, the results qualitatively parallel
the ones from the micelle studies. The presence of the small unila-
mellar vesicles prevented ghrelin but not des-ghrelin from travers-
ing the ﬁlter membrane.
We believe that ghrelin is attached to the membrane to facili-
tate interactions with its speciﬁc membrane-bound target, the
GHS-R receptor. Insertion into the membrane reduces the problem
of ﬁnding its target from a three-dimensional (freely soluble) to a
two-dimensional (gliding in the membrane) search. Previously,
myristoyl and especially palmitoyl groups have been described to
function as membrane-anchors. The long hydrophobic chains of
palmitoyl and myristoyl groups bind relatively strongly to hydro-
phobic membrane interiors. The dissociation constants of octanoic
acid and ghrelin bound to DPC micelles were determined by NMR
chemical shift titration experiments. Assuming a binding stochi-
ometry of 1:1 (peptide/micelle), dissociation constants of 6 lM
(octanoic acid) and <0.1 lM (ghrelin) were found. However, it
should be taken into consideration that more than one moleculee to the micelles as derived from PREs. The numbers are the experimental PREs in
5488 J. Großauer et al. / Bioorg. Med. Chem. 18 (2010) 5483–5488of octanoic acid or ghrelin may bind per micelle and thus these dis-
sociation constants should be interpreted cautiously.
Independent of the binding stochiometry, the mole fraction par-
tition coefﬁcients and unitary Gibbs free energies of ghrelin and
octanoic acid binding to DPC micelles were determined. A rela-
tively high value of DG0u = 9.5 kcal/mol, indicative of tight binding
was found for ghrelin. Considering that the free energy for the
transfer of a free C8 fatty acid from aqueous into a hydrophobic
environment is just 1.5 kcal/mol43 and according to the
Wimley/White scale44 a phenylalanine side chain contributes an-
other 1.1 kcal/mol our experimental ﬁnding could indicate that
additional interactions, for example, between the peptide back-
bone and the polar micelle surface might strengthen the binding
or might be related, at least partially, to the used DPC environment.
For octanoic acid we found DG0u = 8.6 kcal/mol, which is probably
related to the pH of 5 which was used for our studies. The reduced
pH was selected to account for the occurrence of ghrelin in often
acidic environments. At this pH a larger proportion of octanoic acid
is present in neutral form, for which much stronger binding has
previously been reported for free fatty acids.45 Nevertheless, it is
clear that binding of an octanoyl chain alone does not account
for the comparatively tight binding observed for ghrelin. Thus,
the much stronger binding of ghrelin apparently also depends on
the insertion of the hydrophobic aromatic group of Phe4. The
importance of both the Ser3 octanoyl group and Phe4 for binding
to membrane-mimetics is a remarking similarity to the previously
observed role of these two residues in ghrelin function.7–9 There-
fore, the binding to biological membranes might be required for
ghrelin function. The interaction with the GHS receptor might
either depend on ghrelin binding to membrane in order to more
easily ﬁnd its target or the binding to the receptor could involve
simultaneous attachment of ghrelin to the membrane. The neces-
sity of two groups for membrane-binding is in accordance with
similar ﬁndings of other groups, which have shown that two
groups are necessary for stable attachment of various proteins
and peptides to membranes.45–49
5. Conclusions
In conclusion, we have found that the peptide hormone ghrelin
binds to membrane-mimetics via its octanoyl chain attached to
Ser3. The binding is enhanced by additional hydrophobic interac-
tions of the aromatic side-chain of Phe4. Elimination of the octa-
noyl chain is sufﬁcient to prevent membrane attachment as
shown by solution NMR and ultraﬁltration. Relaxation enhance-
ments in a paramagnetic environment were used to show the deep
immersion of the octanoyl alkyl chain and aromatic ring of Phe4.
Thus, the octanoyl group is not only involved in binding to GHS-
R but also functions as a membrane anchor and can therefore more
easily direct ghrelin to its receptor. The fundamental role of the
octanoyl chain on Ser3 and the aromatic group of Phe4 in mem-
brane-binding strikingly resembles the importance of these two
residues for ghrelin function, suggesting a functional importance
of ghrelin binding to membranes.
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